ADMSCs offer promise for Type 1 Diabetes therapy due to their immunomodulatory and regenerative properties. This review highlights current findings, clinical relevance, and challenges in translating ADMSC-based treatments into standard care.
- Vanshika Sood
- Hannah Ricioli
- Reza Yarani